Trial Profile

Phase II trial of AN363 for the treatment of neuropathic pain

Status: Suspended

Phase of Trial: Phase II

Latest Information Update: 17 May 2016

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs AN 363 (Primary)
Indications Neuropathic pain
Focus Proof of concept; Therapeutic Use
Sponsors Saniona

Most Recent Events

09 May 2016 Status changed from planning to suspended, according to a Saniona media release.
09 May 2016 According to a Saniona media release, the company announced that the ongoing investigations on the AN363 compound will be put on hold.
14 Dec 2015 New trial record

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com